Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 54

1.

The lipid mediator lysophosphatidic acid induces folding of disordered peptides with basic amphipathic character into rare conformations.

Juhász T, Mihály J, Kohut G, Németh C, Liliom K, Beke-Somfai T.

Sci Rep. 2018 Sep 28;8(1):14499. doi: 10.1038/s41598-018-32786-4.

2.

Regulation of the Equilibrium between Closed and Open Conformations of Annexin A2 by N-Terminal Phosphorylation and S100A4-Binding.

Ecsédi P, Kiss B, Gógl G, Radnai L, Buday L, Koprivanacz K, Liliom K, Leveles I, Vértessy B, Jeszenői N, Hetényi C, Schlosser G, Katona G, Nyitray L.

Structure. 2017 Aug 1;25(8):1195-1207.e5. doi: 10.1016/j.str.2017.06.001. Epub 2017 Jun 29.

3.

The SH3 domain of Caskin1 binds to lysophosphatidic acid suggesting a direct role for the lipid in intracellular signaling.

Koprivanacz K, Tőke O, Besztercei B, Juhász T, Radnai L, Merő B, Mihály J, Péter M, Balogh G, Vígh L, Buday L, Liliom K.

Cell Signal. 2017 Apr;32:66-75. doi: 10.1016/j.cellsig.2017.01.019. Epub 2017 Jan 16.

PMID:
28104445
4.

Accumulation of the PX domain mutant Frank-ter Haar syndrome protein Tks4 in aggresomes.

Ádám C, Fekete A, Bőgel G, Németh Z, Tőkési N, Ovádi J, Liliom K, Pesti S, Geiszt M, Buday L.

Cell Commun Signal. 2015 Jul 17;13:33. doi: 10.1186/s12964-015-0108-8.

5.

Highly potent dUTPase inhibition by a bacterial repressor protein reveals a novel mechanism for gene expression control.

Szabó JE, Németh V, Papp-Kádár V, Nyíri K, Leveles I, Bendes AÁ, Zagyva I, Róna G, Pálinkás HL, Besztercei B, Ozohanics O, Vékey K, Liliom K, Tóth J, Vértessy BG.

Nucleic Acids Res. 2014 Oct 29;42(19):11912-20. doi: 10.1093/nar/gku882. Epub 2014 Oct 1.

6.

Soluble components of the flagellar export apparatus, FliI, FliJ, and FliH, do not deliver flagellin, the major filament protein, from the cytosol to the export gate.

Sajó R, Liliom K, Muskotál A, Klein A, Závodszky P, Vonderviszt F, Dobó J.

Biochim Biophys Acta. 2014 Nov;1843(11):2414-23. doi: 10.1016/j.bbamcr.2014.07.004. Epub 2014 Jul 25.

7.

Lysophosphatidic acid induces vasodilation mediated by LPA1 receptors, phospholipase C, and endothelial nitric oxide synthase.

Ruisanchez É, Dancs P, Kerék M, Németh T, Faragó B, Balogh A, Patil R, Jennings BL, Liliom K, Malik KU, Smrcka AV, Tigyi G, Benyó Z.

FASEB J. 2014 Feb;28(2):880-90. doi: 10.1096/fj.13-234997. Epub 2013 Nov 18.

8.

Selectivity of kinases on the activation of tenofovir, an anti-HIV agent.

Varga A, Gráczer E, Chaloin L, Liliom K, Závodszky P, Lionne C, Vas M.

Eur J Pharm Sci. 2013 Jan 23;48(1-2):307-15. doi: 10.1016/j.ejps.2012.11.007. Epub 2012 Nov 28.

PMID:
23201309
9.

Unbinding of hyaluronan accelerates the enzymatic activity of bee hyaluronidase.

Iliás A, Liliom K, Greiderer-Kleinlercher B, Reitinger S, Lepperdinger G.

J Biol Chem. 2011 Oct 14;286(41):35699-707. doi: 10.1074/jbc.M111.263731. Epub 2011 Aug 12.

10.

Nucleotide promiscuity of 3-phosphoglycerate kinase is in focus: implications for the design of better anti-HIV analogues.

Varga A, Chaloin L, Sági G, Sendula R, Gráczer E, Liliom K, Závodszky P, Lionne C, Vas M.

Mol Biosyst. 2011 Jun;7(6):1863-73. doi: 10.1039/c1mb05051f. Epub 2011 Apr 20.

PMID:
21505655
11.

The phospholipase A1 activity of lysophospholipase A-I links platelet activation to LPA production during blood coagulation.

Bolen AL, Naren AP, Yarlagadda S, Beranova-Giorgianni S, Chen L, Norman D, Baker DL, Rowland MM, Best MD, Sano T, Tsukahara T, Liliom K, Igarashi Y, Tigyi G.

J Lipid Res. 2011 May;52(5):958-70. doi: 10.1194/jlr.M013326. Epub 2011 Mar 9.

12.

Neonatal FcR overexpression boosts humoral immune response in transgenic mice.

Cervenak J, Bender B, Schneider Z, Magna M, Carstea BV, Liliom K, Erdei A, Bosze Z, Kacskovics I.

J Immunol. 2011 Jan 15;186(2):959-68. doi: 10.4049/jimmunol.1000353. Epub 2010 Dec 8.

13.

GAP43 shows partial co-localisation but no strong physical interaction with prolyl oligopeptidase.

Szeltner Z, Morawski M, Juhász T, Szamosi I, Liliom K, Csizmók V, Tölgyesi F, Polgár L.

Biochim Biophys Acta. 2010 Dec;1804(12):2162-76. doi: 10.1016/j.bbapap.2010.09.010. Epub 2010 Sep 30.

PMID:
20869470
14.

Regulation of ryanodine receptors by sphingosylphosphorylcholine: involvement of both calmodulin-dependent and -independent mechanisms.

Kovacs E, Xu L, Pasek DA, Liliom K, Meissner G.

Biochem Biophys Res Commun. 2010 Oct 15;401(2):281-6. doi: 10.1016/j.bbrc.2010.09.050. Epub 2010 Sep 17.

15.

Structure and mechanism of calmodulin binding to a signaling sphingolipid reveal new aspects of lipid-protein interactions.

Kovacs E, Harmat V, Tóth J, Vértessy BG, Módos K, Kardos J, Liliom K.

FASEB J. 2010 Oct;24(10):3829-39. doi: 10.1096/fj.10-155614. Epub 2010 Jun 3.

16.

Dual coding in alternative reading frames correlates with intrinsic protein disorder.

Kovacs E, Tompa P, Liliom K, Kalmar L.

Proc Natl Acad Sci U S A. 2010 Mar 23;107(12):5429-34. doi: 10.1073/pnas.0907841107. Epub 2010 Mar 8.

17.

Synthesis and properties of a photoactivatable analogue of psychosine (beta-Galactosylsphingosine).

Lankalapalli RS, Baksa A, Liliom K, Bittman R.

ChemMedChem. 2010 May 3;5(5):682-6. doi: 10.1002/cmdc.201000018. No abstract available.

18.

Dissociation of calmodulin-target peptide complexes by the lipid mediator sphingosylphosphorylcholine: implications in calcium signaling.

Kovacs E, Tóth J, Vértessy BG, Liliom K.

J Biol Chem. 2010 Jan 15;285(3):1799-808. doi: 10.1074/jbc.M109.053116. Epub 2009 Nov 12.

19.

New cholesterol-specific antibodies remodel HIV-1 target cells' surface and inhibit their in vitro virus production.

Beck Z, Balogh A, Kis A, Izsépi E, Cervenak L, László G, Bíró A, Liliom K, Mocsár G, Vámosi G, Füst G, Matko J.

J Lipid Res. 2010 Feb;51(2):286-96. doi: 10.1194/jlr.M000372. Epub 2009 Aug 4.

20.

Mechanism of lysophosphatidic acid-induced amyloid fibril formation of beta(2)-microglobulin in vitro under physiological conditions.

Pál-Gábor H, Gombos L, Micsonai A, Kovács E, Petrik E, Kovács J, Gráf L, Fidy J, Naiki H, Goto Y, Liliom K, Kardos J.

Biochemistry. 2009 Jun 23;48(24):5689-99. doi: 10.1021/bi900356r.

PMID:
19432419
21.

Sphingosylphosphorylcholine as a novel calmodulin inhibitor.

Kovacs E, Liliom K.

Biochem J. 2008 Mar 1;410(2):427-37.

PMID:
17979830
22.

Identification of the hydrophobic ligand binding pocket of the S1P1 receptor.

Fujiwara Y, Osborne DA, Walker MD, Wang DA, Bautista DA, Liliom K, Van Brocklyn JR, Parrill AL, Tigyi G.

J Biol Chem. 2007 Jan 26;282(4):2374-85. Epub 2006 Nov 18.

23.

Farnesyl phosphates are endogenous ligands of lysophosphatidic acid receptors: inhibition of LPA GPCR and activation of PPARs.

Liliom K, Tsukahara T, Tsukahara R, Zelman-Femiak M, Swiezewska E, Tigyi G.

Biochim Biophys Acta. 2006 Dec;1761(12):1506-14. Epub 2006 Oct 3.

24.

Synthesis, structure-activity relationships, and biological evaluation of fatty alcohol phosphates as lysophosphatidic acid receptor ligands, activators of PPARgamma, and inhibitors of autotaxin.

Durgam GG, Virag T, Walker MD, Tsukahara R, Yasuda S, Liliom K, van Meeteren LA, Moolenaar WH, Wilke N, Siess W, Tigyi G, Miller DD.

J Med Chem. 2005 Jul 28;48(15):4919-30.

PMID:
16033271
25.

The role of the conserved glycines of ATP-binding cassette signature motifs of MRP1 in the communication between the substrate-binding site and the catalytic centers.

Szentpétery Z, Kern A, Liliom K, Sarkadi B, Váradi A, Bakos E.

J Biol Chem. 2004 Oct 1;279(40):41670-8. Epub 2004 Jul 12.

26.

Nucleotides and transported substrates modulate different steps of the ATPase catalytic cycle of MRP1 multidrug transporter.

Kern A, Szentpétery Z, Liliom K, Bakos E, Sarkadi B, Váradi A.

Biochem J. 2004 Jun 1;380(Pt 2):549-60.

27.

Photolysis of intracellular caged sphingosine-1-phosphate causes Ca2+ mobilization independently of G-protein-coupled receptors.

Meyer zu Heringdorf D, Liliom K, Schaefer M, Danneberg K, Jaggar JH, Tigyi G, Jakobs KH.

FEBS Lett. 2003 Nov 20;554(3):443-9.

28.

Fatty alcohol phosphates are subtype-selective agonists and antagonists of lysophosphatidic acid receptors.

Virag T, Elrod DB, Liliom K, Sardar VM, Parrill AL, Yokoyama K, Durgam G, Deng W, Miller DD, Tigyi G.

Mol Pharmacol. 2003 May;63(5):1032-42.

PMID:
12695531
29.

Stereochemical properties of lysophosphatidic acid receptor activation and metabolism.

Yokoyama K, Baker DL, Virag T, Liliom K, Byun HS, Tigyi G, Bittman R.

Biochim Biophys Acta. 2002 May 23;1582(1-3):295-308. Review.

PMID:
12069841
30.

A single amino acid determines lysophospholipid specificity of the S1P1 (EDG1) and LPA1 (EDG2) phospholipid growth factor receptors.

Wang DA, Lorincz Z, Bautista DL, Liliom K, Tigyi G, Parrill AL.

J Biol Chem. 2001 Dec 28;276(52):49213-20. Epub 2001 Oct 16.

31.

Sphingosylphosphocholine is a naturally occurring lipid mediator in blood plasma: a possible role in regulating cardiac function via sphingolipid receptors.

Liliom K, Sun G, Bünemann M, Virág T, Nusser N, Baker DL, Wang DA, Fabian MJ, Brandts B, Bender K, Eickel A, Malik KU, Miller DD, Desiderio DM, Tigyi G, Pott L.

Biochem J. 2001 Apr 1;355(Pt 1):189-97.

32.

Identification of Edg1 receptor residues that recognize sphingosine 1-phosphate.

Parrill AL, Wang D, Bautista DL, Van Brocklyn JR, Lorincz Z, Fischer DJ, Baker DL, Liliom K, Spiegel S, Tigyi G.

J Biol Chem. 2000 Dec 15;275(50):39379-84.

33.

Organization-dependent effects of toxic bivalent ions microtubule assembly and glycolysis.

Liliom K, Wágner G, Pácz A, Cascante M, Kovács J, Ovádi J.

Eur J Biochem. 2000 Aug;267(15):4731-9.

34.

Sphingosylphosphorylcholine is a bona fide mediator regulating heart rate.

Liliom K, Bünemann M, Sun G, Miller D, Desiderio DM, Brandts B, Bender K, Pott L, Nusser N, Tigyi G.

Ann N Y Acad Sci. 2000 Apr;905:308-10. No abstract available.

PMID:
10818471
35.

Pharmacological characterization of phospholipid growth-factor receptors.

Tigyi G, Fischer DJ, Baker D, Wang DA, Yue J, Nusser N, Virag T, Zsiros V, Liliom K, Miller D, Parrill A.

Ann N Y Acad Sci. 2000 Apr;905:34-53. Review.

PMID:
10818440
36.

A new potent calmodulin antagonist with arylalkylamine structure: crystallographic, spectroscopic and functional studies.

Harmat V, Böcskei Z, Náray-Szabó G, Bata I, Csutor AS, Hermecz I, Arányi P, Szabó B, Liliom K, Vértessy BG, Ovádi J.

J Mol Biol. 2000 Mar 31;297(3):747-55.

PMID:
10731425
37.

Enhanced association of mutant triosephosphate isomerase to red cell membranes and to brain microtubules.

Orosz F, Wágner G, Liliom K, Kovács J, Baróti K, Horányi M, Farkas T, Hollán S, Ovádi J.

Proc Natl Acad Sci U S A. 2000 Feb 1;97(3):1026-31.

38.

Combined enhancement of microtubule assembly and glucose metabolism in neuronal systems in vitro: decreased sensitivity to copper toxicity.

Liliom K, Wágner G, Kovács J, Comin B, Cascante M, Orosz F, Ovádi J.

Biochem Biophys Res Commun. 1999 Oct 22;264(2):605-10.

PMID:
10529410
39.

Naturally occurring analogs of lysophosphatidic acid elicit different cellular responses through selective activation of multiple receptor subtypes.

Fischer DJ, Liliom K, Guo Z, Nusser N, Virág T, Murakami-Murofushi K, Kobayashi S, Erickson JR, Sun G, Miller DD, Tigyi G.

Mol Pharmacol. 1998 Dec;54(6):979-88.

PMID:
9855625
40.

Identification of a novel growth factor-like lipid, 1-O-cis-alk-1'-enyl-2-lyso-sn-glycero-3-phosphate (alkenyl-GP) that is present in commercial sphingolipid preparations.

Liliom K, Fischer DJ, Virág T, Sun G, Miller DD, Tseng JL, Desiderio DM, Seidel MC, Erickson JR, Tigyi G.

J Biol Chem. 1998 May 29;273(22):13461-8.

41.

Growth factor-like phospholipids generated after corneal injury.

Liliom K, Guan Z, Tseng JL, Desiderio DM, Tigyi G, Watsky MA.

Am J Physiol. 1998 Apr;274(4):C1065-74. doi: 10.1152/ajpcell.1998.274.4.C1065.

PMID:
9575804
42.

Role of lysophosphatidic acid in endothelin-1- and hematoma-induced alteration of cerebral microcirculation.

Yakubu MA, Liliom K, Tigyi GJ, Leffler CW.

Am J Physiol. 1997 Aug;273(2 Pt 2):R703-9.

PMID:
9277558
43.

Local anesthetics inhibit receptors coupled to phosphoinositide signaling in Xenopus oocytes.

Tigyi J, Tigyi G, Liliom K, Miledi R.

Pflugers Arch. 1997 Feb;433(4):478-87.

PMID:
9000427
44.

Molecular cloning of a high-affinity receptor for the growth factor-like lipid mediator lysophosphatidic acid from Xenopus oocytes.

Guo Z, Liliom K, Fischer DJ, Bathurst IC, Tomei LD, Kiefer MC, Tigyi G.

Proc Natl Acad Sci U S A. 1996 Dec 10;93(25):14367-72.

45.

A novel membrane receptor with high affinity for lysosphingomyelin and sphingosine 1-phosphate in atrial myocytes.

Bünemann M, Liliom K, Brandts BK, Pott L, Tseng JL, Desiderio DM, Sun G, Miller D, Tigyi G.

EMBO J. 1996 Oct 15;15(20):5527-34.

46.
47.

Xenopus oocytes express multiple receptors for LPA-like lipid mediators.

Liliom K, Murakami-Murofushi K, Kobayashi S, Murofushi H, Tigyi G.

Am J Physiol. 1996 Mar;270(3 Pt 1):C772-7.

PMID:
8638656
48.
49.

Anti-calmodulin potency of indol alkaloids in in vitro systems.

Molnár A, Liliom K, Orosz F, Vértessy BG, Ovádi J.

Eur J Pharmacol. 1995 Oct 15;291(2):73-82.

PMID:
8566178
50.

Characterization of tubulin-alkaloid interactions by enzyme-linked immunosorbent assay.

Liliom K, Lehotzky A, Molnár A, Ovádi J.

Anal Biochem. 1995 Jun 10;228(1):18-26.

PMID:
8572281

Supplemental Content

Loading ...
Support Center